...
首页> 外文期刊>Medical Hypothesis, Discovery & Innovation Ophthalmology Journal >Macular Inner Retinal Layer Thinning in Diabetic Patients without Retinopathy Measured by Spectral Domain Optical Coherence Tomography
【24h】

Macular Inner Retinal Layer Thinning in Diabetic Patients without Retinopathy Measured by Spectral Domain Optical Coherence Tomography

机译:用光谱域光学相干断层扫描技术测量无视网膜病变的糖尿病患者黄斑内视网膜层变薄

获取原文
           

摘要

The aim of this study was to use Spectral Domain-Optical Coherence Tomography (SD-OCT) to measure the thickness of the Macular Inner Retinal Layer (MIRL) and compare the results between diabetic patients with no signs of retinopathy and healthy subjects. Overall, 47 type 2 diabetic patients without clinical signs of retinopathy were prospectively analyzed along with 36 healthy subjects. This study excluded patients with other systemic or ocular diseases. All patients had their MIRL thickness measured by RTVue-100 SD-OCT (7x7 mm macular grid). The MIRL thickness is provided by the ganglion cell complex scan (comprised of the retinal nerve fiber, ganglion cell, and inner plexiform layers). Only one eye was randomly selected if both were eligible for analysis. Mean age was similar between the two groups (diabetic patients: 57.3 ± 10.6 and control subjects: 60.2 ± 12.2 years) (P = 0.19). No significant differences regarding optic disc area and cup-to-disc ratio was observed in the comparison of the two groups (P ≥ 0.38 for both comparisons). In patients with diabetes, the average MIRL was significantly thinner when compared to controls (91.6 versus 96.2 micrometer (μm); P = 0.02). Regional analysis revealed superior and inferior MIRL to be significantly thinner in patients with diabetes than the controls (P ≤ 0.04). The juxtafoveal area was compromised (thinned) in 70% of diabetic eyes, classified as abnormal (P 1%; compared to the device’s normative database). In conclusion, patients with type 2 diabetes without clinical evidence of retinopathy had lower MIRL average values when compared to the control group. This can be explained by the ischemia and retinal tissue injury caused by diabetes even in early stages of diabetic retinopathy, which can affect MIRL thickness. Possible implications of these findings on diagnosis and treatment of diabetic retinopathy requires further investigation.
机译:这项研究的目的是使用光谱域光学相干断层扫描(SD-OCT)测量黄斑内视网膜层(MIRL)的厚度,并比较无视网膜病变迹象的糖尿病患者和健康受试者的结果。总体上,前瞻性分析了47例无视网膜病变临床体征的2型糖尿病患者以及36名健康受试者。该研究排除了患有其他全身或眼部疾病的患者。所有患者均通过RTVue-100 SD-OCT(7x7 mm黄斑网格)测量其MIRL厚度。 MIRL厚度由神经节细胞复合物扫描(由视网膜神经纤维,神经节细胞和内部丛状层组成)提供。如果两只眼睛都有资格进行分析,则只随机选择一只眼睛。两组的平均年龄相似(糖尿病患者:57.3±10.6岁,对照组:60.2±12.2岁)(P = 0.19)。在两组的比较中,未发现有关视盘面积和杯碟比的显着差异(两个比较的P≥0.38)。与对照组相比,糖尿病患者的平均MIRL显着降低(91.6对96.2微米(μm); P = 0.02)。区域分析显示,与对照组相比,糖尿病患者的MIRL优,劣MIRL要薄得多(P≤0.04)。在70%的糖尿病眼中,靠近中央凹的区域变薄(变薄),被分类为异常(P <1%;与该设备的标准数据库相比)。总之,与对照组相比,没有临床证据的视网膜病变的2型糖尿病患者的MIRL平均值较低。这可以用糖尿病引起的局部缺血和视网膜组织损伤来解释,即使在糖尿病性视网膜病的早期也可能会影响MIRL厚度。这些发现对糖尿病性视网膜病的诊断和治疗的可能含义需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号